Comparison of the responsiveness of two different asthma-specific QOL measures (AQLQ and cAQOL) in Korean patients with persistent asthma

Inclusion Criteria:

• Patient aged 20-70 years

• Patient diagnosed with asthma over six months ago

• Asthma diagnosis

  • Airway reversibility, FEV1 ≥ 12% and 200mL or
  • Airway hyper-responsiveness, PC20 < 16 mg/mL or
  • More than two weeks, more than 2 times a day in excess of 20% PEFR diurnal variability patient

• FEV1 55-100% of predicted value patient

• Inhaled corticosteroids alone or inhaled corticosteroids and beta agonists used patient

• Currently, at least if you have one or more asthma symptoms, asthma control test (ACT • Asthma Control Test) score of less than 19 characters

• Patients who sufficiently listen to the purpose and content of this trial and the properties of investigational products and voluntarily agree with the participation to sign a written consent approved by IRB of Ajou University Medical Center before the participation in this trial

Exclusion Criteria:

• Current smoking or smoking in the past 15packyears
• Patients who show a symptom of an acute disease within 14 days before the beginning of this trial (administration of trial medication)
• Recent changes in asthma treatment for 28days
• Chronic diseases that affect the quality of life

asthma control patient